Induction of immune tolerance on memory B cells specific to transplantation carbohydrate antigens was studied in the experimental animal model of 1,3galactosyltransferase knockout (KO) mice, which lack the -gal epitope (Gal 1-3Gal 1-4GlcNAc-R) and can produce the anti-Gal antibody against it. Memory anti-Gal B cells were generated by immunization of KO mice with pig kidney membranes, i.e. xenogeneic cell membranes expressing an abundance of -gal epitopes. Lymphocytes including memory anti-Gal B cells were administered into lethally irradiated KO mice, together with syngeneic wild type (WT) lymphocytes expressing -gal epitopes. Memory anti-Gal B cells were completely tolerized after being in vivo for 14 days with WT lymphocytes. This was indicated by the lack of anti-Gal IgG response following immunization with pig kidney membranes vs. the extensive anti-Gal response in mice that did not receive WT lymphocytes. Tolerance induction was prevented if T cells were activated by alloantigens. This tolerance was highly specific to anti-Gal B cells and did not affect memory B cells with closely related specificity, such as B cells with anti-blood group A specificity. Tolerance induction on anti-Gal B cells was found to be time dependent and required >10 days of in vivo exposure of these B cells to WT lymphocytes. These observations suggest a novel method for induction of tolerance to transplantation carbohydrate antigens in humans, by in vitro transduction of autologous blood lymphocytes with an adenovirus containing the corresponding glycosyltransferase gene, and administration of the transduced cells into the circulation, after removal of natural antibodies to the antigen.
INTRODUCTION
The study of immune tolerance to cell surface carbohydrate antigens, such as blood group ABO antigens, is of interest primarily in the area of transplantation of organs or tissues expressing incompatible carbohydrate antigens. Studying this type of tolerance has become feasible in the recent years with the generation of 1,3galactosyltransferase ( 1,3GT) knockout (KO) mice (1) . These KO mice are syngeneic to the wild type (WT) C57BL/6 strain, but they lack the -gal epitope (Gal 1-3Gal 1-4GlcNAc-R) because of the disruption of the 1,3GT gene. This gene encodes the glycosyltransferase that synthesizes -gal epitopes. The -gal epitope is absent in humans because of evolutionary inactivation of the 1,3GT
gene (2, 3) . Nevertheless, this epitope comprises part of the core structure of blood group B antigen, where a fucose is linked to the penultimate galactose (i.e. Gal 1-3(Fuc 1-2)Gal 1-4GlcNAc-R) and of blood group A which is similar to blood group B, but also has an N-acetyl group (NAc) linked to the terminal galactosyl (GalNAc 1-3(Fuc 1-2)Gal 1-4GlcNAc-R) (4, 5) .
The -gal epitope is expressed on cells of nonprimate mammals (including mice) and in New World monkeys, all of which have active 1,3GT (2, 3) . Humans, apes and Old World monkeys lack -gal epitopes, and produce the natural anti-Gal antibody against it as ~1% of circulating immunoglobulins (6) (7) (8) , because of continuous stimulation by gastrointestinal bacteria (9) . Anti-Gal is of clinical significance as the interaction between this antibody and -gal epitopes on pig cells prevents xenotransplantation of pig organs into humans and monkeys (10) (11) (12) (13) . In addition, most of the elicited anti-blood group antibodies in patients that reject ABO incompatible kidney allografts, are in fact anti-Gal antibodies that bind to the core -gal epitope within the incompatible blood groups A or B antigens (14) .
In contrast to WT mice, which are immunotolerant to the -gal epitope, KO mice lost this tolerance and readily produce anti-Gal IgG in high titers, following repeated immunizations with For personal use only. on November 12, 2017 . by guest www.bloodjournal.org From xenogeneic membranes expressing -gal epitopes, such as pig kidney membranes (PKM) (15, 16) .
Chimerism studies with mouse bone marrow (BM) cells expressing -gal epitopes have demonstrated the induction of tolerance to -gal epitopes in KO mice (17) (18) (19) (20) . These studies led to the conclusion that BM cells expressing -gal epitope can "educate" the immune system to "regard" this epitope as a self antigen.
Our objective has been to determine whether there are cells, other than BM cells, that can induce tolerance to the -gal epitope. For this purpose we studied the ability of syngeneic WT lymphocytes (i.e. lymphocytes with the same antigenic makeup as KO lymphocytes, but which also express ~1.5x10 5 -gal epitopes/cell [21] ) to induce such tolerance. In a recent study (22), we have reported that as few as 2x10 6 syngeneic WT lymphocytes from C57BL/6 mice, administered into naïve KO mice, tolerized them to the extent that the mice were incapable of producing anti-Gal following multiple PKM immunizations. This study implied that exposure of naïve B cells with an anti-carbohydrate specificity to the cognate carbohydrate antigen on syngeneic lymphocytes, results in tolerization of these B cells (22).
The study of tolerance induction on naïve anti-carbohydrate B cells does not fully simulate anticarbohydrate immune response in humans. This is because human B cells capable of producing anti-blood group A or B, or anti-Gal antibodies, include a large proportion of memory B cells primed by carbohydrate epitopes on gastrointestinal bacteria (9, 23, 24 
Measurement of anti-Gal IgG production
Anti-Gal IgG production was measured in serum samples obtained one week after the second immunization with PKM, as previously described (16) . Anti-Gal activity was determined in sera placed into ELISA wells at various dilutions in PBS containing 1% bovine serum albumin (BSA), using synthetic -gal epitopes linked to BSA ( -gal-BSA, Dextra, Reading, UK), as solid phase antigen. Peroxidase coupled goat anti-mouse IgG (Accurate Chemicals Labs, Westbury, NY) was used as secondary antibody.
Analysis of anti-blood group A antibody production
The production of anti-blood group A antibodies in mice immunized with human blood group A red cell membranes, was measured by ELISA with red cell membranes as solid phase antigen, as previously
For personal use only. on November 12, 2017 . by guest www.bloodjournal.org From described (14) . Lysed blood group A red cell membranes were washed, brought to a concentration of 2 mg/ml in carbonate buffer (pH 9.5), dried overnight as 50µl aliquots per well in ELISA plates (Falcon 3912), resulting in firm adherence to the wells. Wells were blocked with 1% BSA in PBS. Serum samples were adsorbed twice on equal volume of blood group O red cell membranes, to remove anti-human red cell antibodies that are not anti-A. Sera were placed in the ELISA wells, at two fold serial dilutions in PBS-BSA, in 50µl aliquots. After 2h, the plates were washed with PBS containing 0.05% Tween-20, then alkaline-phosphatase coupled goat anti-mouse IgG (Sigma St. Louis, diluted 1:1000) was added as secondary antibody. The color reaction was developed with p-nitrophenylphosphate (Sigma) and absorbance measured at 405nm.
ELISPOT analysis
The ELISPOT assay, used to measure the proportion of anti-Gal secreting B cells was performed as 
Separation of lymphocyte subpopulations by magnetic beads
Spleen lymphocytes were incubated for 30min with anti-IgG, or anti-CD3 coated biodegradable magnetic microbeads (Miltenyi Biotec, Auburn, CA). Subsequently, the lymphocytes binding the beads WT lymphocytes within KO recipients were identified by staining with the FITC coupled Bandeiraea (Griffonia) simplicifolia IB4 lectin (BS lectin) (Sigma). This lectin binds to -gal epitopes on various cells (2, 3) . Lymphocytes (2x10 6 /ml) were incubated with 10µg/ml of FITC-BS lectin for 30min at 4 o C.
Subsequently the cells were washed and subjected to flow cytometry analysis as above.
Heart transplantation
WT hearts obtained from C57BL/6 mice were heterotopically transplanted in the abdominal cavity of KO mice by connecting the WT aorta to the KO aorta and WT pulmonary artery to the KO inferior vena cava, as previously described (22). This transplantation was performed in tolerized KO mice and in control KO mice producing anti-Gal. The transplanted heart function was determined by daily palpation. 
RESULTS

Characterization of memory anti-Gal B cells
Memory anti-Gal B cells could be generated by PKM immunization of KO mice (16) . However, such immunization induces also anti-Gal production (16) It should be stressed that anti-Gal response could be observed in recipients of memory anti-Gal B cells also after one PKM immunization. However, anti-Gal response was 2-8 fold lower than that observed after two PKM immunizations. We chose to study tolerance induction after two PKM immunizations in order to demonstrate prevention of anti-Gal response in mice that are exposed for prolonged periods to xenoantigens. Repeated immunization with 50mg PKM simulated the continuous presence of a xenograft expressing -gal epitopes with a size comparable to that of a mouse kidney. 
Tolerance induction on memory anti-Gal B cells by WT lymphocytes
The ability of -gal epitopes on WT lymphocytes to tolerize memory anti-Gal B cells was studied by adoptive transfer of 20x10 6 , 2x10 6 or 0.2x10 6 WT lymphocytes together with 20x10 6 lymphocytes from PKM immunized mice. The mice were immunized with PKM, on days 14 and 21 post adoptive transfer and anti-Gal IgG production evaluated on day 28. When 20x10 6 or 2x10 6 WT lymphocytes were administered into the KO recipient of memory anti-Gal B cells, anti-Gal activity was marginal even at a serum dilution of 1:50 ( Fig. 2A) . 2B ). We have observed a similar tolerizing effect by transplantation of WT heart into recipients of memory anti-Gal B cells (submitted). Taken together, these studies suggest that various syngeneic cells expressing -gal epitopes may induce similar tolerance on anti-Gal B cells.
The tolerance induction described in Figs. 2A and 2B was studied in lethally irradiated KO recipients. It was of interest to determine whether a similar tolerance can be achieved in recipients of
For personal use only. on November 12, 2017. by guest www.bloodjournal.org From memory anti-Gal B cells in which the lymphoid system is intact, i.e. in recipients that were not irradiated. The tolerance inducing study described in Fig. 2A was repeated in naïve KO mice (unirradiated) receiving 20x10 6 lymphocytes including memory anti-Gal B cells, from PKM immunized mice, and 20x10 6 WT lymphocytes. Anti-Gal production in the control mice that lack WT lymphocytes was significantly lower than that observed in irradiated recipients (Fig. 2C) , possibly because many of the administered memory anti-Gal B cells fail to reach the sites of antibody production (e.g. germinal centers) in secondary lymphoid organs. This is because such sites are occupied by the original lymphocytes of the recipient. Nevertheless, mice receiving also WT lymphocytes displayed tolerance, as they failed to produce anti-Gal in significant titers following two PKM immunizations (Fig. 2C ). These data imply that tolerance induction by WT lymphocytes can be observed also in recipients of memory anti-Gal B cells, in which the immune system is intact.
Tolerance induction by WT lymphocytes was further supported by studies on transplantation of WT hearts. Five of the mice tolerized by 20x10 6 WT lymphocytes and immunized twice with PKM ( Fig.   2A ), were transplanted with WT heart on day 28 post adoptive transfer. These WT hearts were not rejected and continued to function for at least 2 months. In contrast, all 5 control recipients that did not receive WT lymphocytes and which produced anti-Gal ( Fig. 2A) , rejected the transplanted WT hearts within 1h, as in our previous study (22) . These data support the observation on the lack of anti-Gal in the tolerized mice.
Production of this antibody, even in low amounts, would have resulted in its binding to -gal epitopes on the endothelial cells of the transplanted WT hearts and rejection of these grafts within days or few weeks.
It should be stressed that mice receiving 20x10 6 WT lymphocytes and 20x10 6 KO lymphocytes separately in an 1h interval, displayed complete tolerance, as mice receiving the two populations together
(not shown). This implies that the lack of anti-Gal response is not associated with any unknown effect on 
Kinetics of tolerance induction by WT lymphocytes
Tolerance induction by WT lymphocytes was found to be a time dependent process. Lethally irradiated KO recipients of lymphocytes from PKM immunized KO mice and of 2x10 6 WT lymphocytes, produced anti-Gal effectively when they were immunized twice with PKM, starting on day 1, or day 3 post adoptive transfer (Fig. 3A) . The absence of cells producing anti-Gal in the tolerized mice was further supported by ELISPOT assays for B cells secreting anti-Gal. Anti-Gal secreting cells were readily detected as multiple spots in control PKM immunized KO recipients (Fig. 3B) . However, almost no anti-Gal secreting cells were found in tolerized KO mice immunized with PKM (Fig. 3B) . These findings strongly suggest that tolerized KO mice that are repeatedly immunized with PKM, lack anti-Gal secreting cells, whereas such cells readily 
WT lymphocytes in tolerized KO mice
It could be argued that the observed lack of anti-Gal response in tolerized KO mice may be the result of preferential proliferation of WT lymphocytes following PKM immunizations. The proportion of WT lymphocytes in spleen of these mice was determined by staining with BS lectin, which binds specifically to -gal epitopes on cells (2,3). KO lymphocytes are not stained by BS lectin (Fig. 4A ), whereas this lectin stains WT lymphocytes as they all express -gal epitopes (Fig. 4B) . In all KO recipients tolerized by WT lymphocytes and which were immunized twice with PKM, WT lymphocytes displayed <5% of spleen lymphocytes (Figs. 4C and 4D) . A similar low proportion of WT lymphocytes was observed in the mesenteric lymph nodes (not shown). Since each of the spleens in these mice contained ~1x10 8 lymphocytes, the amount of WT lymphocytes did not exceed 5x10 6 per spleen. As the total number of lymphocytes in the peripheral lymphoid organs is <4x10 8 , the number of WT lymphocytes within the tolerized mice is no more than 20x10 6 per mouse. As indicated in our previous study (22), in vitro adsorption of sera from control mice producing anti-Gal, on as much as 1x10 8 WT lymphocytes/ml, did not affect significantly this antibody activity. Taken together, these findings strongly suggest that the number of -gal epitopes on WT lymphocytes in the tolerized mice is not sufficient for effective adsorption of anti-Gal.
Tolerance induction by WT lymphocytes is specific to memory anti-Gal B cells
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The specificity of tolerance induced by WT lymphocytes, was demonstrated by analysis of anti -blood group A immune response. Blood group A differs from the -gal epitope only in that an N-acetyl group is linked to the terminal galactosyl and a fucose is linked to the penultimate galactosyl unit. Mice were repeatedly immunized with 50mg human blood group A red cell membranes and 50mg PKM. This resulted in the generation of both memory anti-A and memory anti-Gal B cells. Twenty million lymphocytes pooled from these mice, and which included both types of memory B cells were administered into irradiated KO recipients, together with 20x10 6 WT lymphocytes. Two weeks post adoptive transfer, these recipients were immunized simultaneously with PKM and with blood group A red cell membranes.
This immunization was repeated on day 21. Anti-Gal and anti-A productions were measured on day 28 by the corresponding ELISAs. Memory anti-Gal B cells were tolerized in these mice, as indicated by the lack of anti-Gal response, whereas control mice that did not receive WT lymphocytes, readily produced antiGal (open and closed circles in Fig. 5, respectively) . In contrast, anti-A memory B cells were not affected by WT lymphocytes. This was indicated by the finding that production of anti-A IgG in mice receiving WT lymphocytes, was similar to that observed in control mice that did not receive WT lymphocytes (open and closed squares in Fig. 5 , respectively). These findings imply that tolerance induction by WT lymphocytes is specific to memory anti-Gal B cells, and has no effect on memory B cells recognizing other structurally related carbohydrate antigens.
Analysis of anti-Gal B cells in tolerized mice by flow cytometry
Previous studies on the mechanism of tolerance induction to a variety of protein antigens and DNA antigens were performed in mice that were transgenic for the antibody and also produced the antigen in (Fig. 6) . Similar staining performed with lymphocytes from tolerized mice that were also PKM immunized, revealed no cells binding -gal BSA (Fig. 6 ). This suggests that anti-Gal B cells were deleted in the tolerized mice. It should be stressed, however, that because of the small number of stained anti-Gal cells, this analysis is not sensitive enough to determine the actual fate of memory anti-Gal B cells within the tolerized mice. An appropriate anti-carbohydrate transgenic animal model will enable reliable visual follow up of antigen specific B cells in the presence of tolerizing lymphocytes expressing the cognate antigen. Such a model will allow for accurate identification of the mechanism involved in the tolerization of anti-carbohydrate B cells.
Prevention of tolerance induction by T cell activation
The immune response to N-(asparagine) linked carbohydrate antigens, such as ABO blood group antigens and the -gal epitope, differs from the immune response to protein antigens in that carbohydrate antigen seem to be incapable of activating T cells. This is because epitopes on N-linked carbohydrate chains protrude too far from the surface of antigen presenting cells (APC) to allow for the accessory molecules of the T cell receptor to engage the corresponding ligands of the surface of APC (33) . Accordingly, we have previously shown that T cells can not be directly activated by -gal epitopes (16) . T cell activation by an alloantigen was found to inhibit tolerance induction. KO mice received 2x10 6 WT lymphocytes on H-2bxd background, together with 20x10 6 lymphocytes from PKM immunized mice, then immunized with PKM on days 14 and 21 post adoptive transfer. These mice were not tolerized and produced anti-Gal IgG (Fig. 7) . The activity of this antibody was somewhat lower than that in control mice receiving the same KO lymphocytes but no WT lymphocytes. In contrast, mice receiving the same memory anti-Gal B cells and 2x10 6 syngeneic WT C57BL/6 lymphocytes, were tolerized as indicated by the low anti-Gal activity (Fig. 7) . These findings strongly suggest that T cells activated by the H-2d alloantigen expressed on the semi-allogeneic WT lymphocytes, rescue memory anti-Gal B cells from being tolerized by -gal epitopes on these WT lymphocytes. These rescued memory anti-Gal B cells were readily activated by -gal epitopes on the immunizing PKM.
DISCUSSION
The present study demonstrates in vivo tolerization of memory anti-Gal B cells by syngeneic WT lymphocytes expressing the -gal epitope. In a previous study we demonstrated a similar tolerance induction on naïve anti-Gal B cells (22). Taken together, these two studies suggest that both naïve and memory anti-carbohydrate B cells can be tolerized when their B cell receptors (BCR) engage the cognate carbohydrate antigen on syngeneic lymphocytes (Fig. 8 ). This phenomenon of tolerance induction by syngeneic lymphocytes expressing the tolerizing carbohydrate antigen is novel. Previous studies in KO
demonstrated tolerance induction on naïve anti-Gal B cells, by chimerism with BM cells expressing -gal epitopes (17) (18) (19) (20) . The present study and our previous report (22) are the first to indicate that such tolerance induction is not an exclusive characteristic of BM cells, as it can be induced also by lymphocytes expressing the cognate carbohydrate antigen. Moreover, the tolerance can be induced on both naïve and memory anti-Gal B cells. This tolerance is highly specific as demonstrated by the effective activation of memory B cells with anti-A specificity in mice tolerized for memory anti-Gal B cells (Fig. 5) .
The mechanism by which naïve and memory anti-Gal B cells are tolerized is not clear at present.
Staining with the cognate antigen suggested the deletion of the tolerized cells. However, a reliable identification of the tolerizing mechanism will require the use of an experimental animal model that is transgenic for the anti-carbohydrate antibody. In such a model, the anti-carbohydrate B cells will comprise a large proportion of the total B cell population. Deletion, anergy, or receptor editing in the tolerized B cell population, will be possible to track in anti-carbohydrate transgenic mice by the use of a genetic marker, or by the binding of the cognate antigen and analysis by flow cytometry.
The inability to induce tolerance in mice in which T cells are activated by alloantigen (Fig. 7) , strongly suggest that anti-carbohydrate B cells engaging the cognate antigen on lymphocytes may escape tolerance induction, if T cell help is provided. Our previous studies indicated that in order for anti-Gal B cells to be activated, these cells require T cell help (16) . In the case of PKM immunization, this help is provided by T cells activated by the many processed and presented immunogenic xenopeptides originating in the immunizing pig membranes (16) . The present study suggests that the T cell help, is also important in rescuing anti-Gal B cells from being tolerized (Fig. 8) . It may be possible that the presented tolerance reflects a more general phenomenon associated with the previously described antigen specific B cell suppression by multihaptenated polymers (34) . In that study Dintzis and Dintzis reported that multihaptenated FITC-dextran downregulates anti-FITC production in mice immunized with FITCFor personal use only. on November 12, 2017 . by guest www.bloodjournal.org From ovalbumin (34) . It remains to be determined whether dextran bearing multiple -gal epitopes can induce a similar tolerizing effect in the presence of xenogeneic membranes expressing -gal epitopes, and whether the immune complexes between the natural anti-Gal and the multihaptenated polymer have no detrimental effects on recipients of such polymers.
Tolerance induction on memory anti-Gal B cells was found to be a time dependent process. At least 10 days were required for inducing tolerance by WT lymphocytes within the KO recipients (Fig. 3A) .
As suggested in the model presented in Fig. 8 , tolerance induction requires memory anti-Gal B cells and WT lymphocytes to "find each other", in order to establish a physical contact between BCR on the B cell and -gal epitopes on the WT lymphocyte. In the absence of T cell help, this interaction elicits a tolerizing signal to the B cell. Prevention of tolerance induction by activated helper T cells is likely to be the reason for the lack of tolerance in KO recipients that were immunized by PKM, on days 1 or 3 post adoptive transfer (Fig. 3A) . Immunization with PKM prior to the tolerization of memory anti-Gal B cells results in the activation of a large number of helper T cells by the numerous immunogenic pig xenopeptides (16) . As in the case of lack of tolerance with semi-allogeneic WT lymphocytes (Fig. 7) , it is possible that these activated T cells rescue memory anti-Gal B cells, which otherwise would later be tolerized by -gal epitopes on WT lymphocytes.
Our observations on tolerization of anti-carbohydrate B cells may be of clinical significance, since they suggest a novel approach for inducing a similar tolerance to ABO incompatible blood group antigens on allografts, or to -gal epitopes on xenografts. One could hypothesize that autologous human blood lymphocytes may be manipulated in vitro to express these carbohydrate antigens. This may be achieved by 
Anti-A (
) and anti-Gal ( ) IgG production in KO recipients of 20x10 6 KO lymphocytes that include memory anti-A and memory anti-Gal B cells, and 20x10 6 WT lymphocytes (open symbols), or no WT lymphocytes (closed symbols). Anti-Gal activity was measured by absorbance at 492nm and anti-A activity measured at 405nm. Each data shows the mean ± S.E. (n=5). Statistical analysis by Student's t-test indicated significant differences between groups ( ) and ( ) at all serum dilutions (p<0.05). No significant difference was found between groups ( ) and ( ). 
